Effect of Hepatitis C Treatment with Ombitasvir/Paritaprevir/R + Dasabuvir on Renal, Cardiovascular and Metabolic Extrahepatic Manifestations: A Post-Hoc Analysis of Phase 3 Clinical Trials.
about
Trend of estimated glomerular filtration rate during ombistasvir/paritaprevir/ritonavir plus dasabuvir ± ribavirin in HIV/HCV co-infected patients.Improvement of Hepatic and Extrahepatic Complications from Chronic Hepatitis C After Antiviral Treatment: A Retrospective Analysis of German Sickness Fund DataChronic hepatitis C, atherosclerosis and cardiovascular disease: What impact of direct-acting antiviral treatments?
P2860
Effect of Hepatitis C Treatment with Ombitasvir/Paritaprevir/R + Dasabuvir on Renal, Cardiovascular and Metabolic Extrahepatic Manifestations: A Post-Hoc Analysis of Phase 3 Clinical Trials.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Effect of Hepatitis C Treatmen ...... is of Phase 3 Clinical Trials.
@en
type
label
Effect of Hepatitis C Treatmen ...... is of Phase 3 Clinical Trials.
@en
prefLabel
Effect of Hepatitis C Treatmen ...... is of Phase 3 Clinical Trials.
@en
P2093
P2860
P1476
Effect of Hepatitis C Treatmen ...... is of Phase 3 Clinical Trials.
@en
P2093
Daniel E Cohen
Eric Cohen
Mariem Charafeddine
Tram T Tran
Yanjun Bao
Yuri Sanchez Gonzalez
P2860
P2888
P304
P356
10.1007/S40121-017-0171-0
P50
P577
2017-09-22T00:00:00Z